Archive for April, 2008

What when where: four in four

Monday, April 21st, 2008

In the next four weeks there are no less than four conferences to go to, one a week. They are, in chronological order:

  • Conference on Securities Litigation, 28, 29 April, London (programme)
  • Corporate Governance and Responsible Investment, 6, 7 May, Copenhagen (programme)
  • Global Shareholder Activism Conference, 15, 16 May, Paris (programme)
  • Pension Fund Investment World Nordic 2008, 19, 20 May, Stockholm (programme)

London is more geared toward the topic of securities litigation for a legal practitioner audience, Copenhagen and Stockholm are more about corporate governance for investors and Paris is a mix of the two. (Also see this previous post.)

Wrapping it up, 19 April 2008

Saturday, April 19th, 2008

Three items of note this time, one bulletin, two articles.

Lovells LLP’s class action practice has published its latest bulletin (April 2008). Several members of the practice contribute to it, a number writing about the respective European and US jurisdictions in which they practice. Contributions cover the latest developments in France and the possibility of its adoption of a group litigation procedure, the scope of Germany’s KapMuG and the European Commission and ‘collective redress’.

The first article is entitled Aggregate Litigation across the Atlantic and the Future of American Exceptionalism, by Prof Richard A. Nagareda, lecturer at Vanderbilt University School of Law. (With thanks to the Drug and Device Law blog.) From the abstract:

This article analyzes the emerging phenomenon of trans-Atlantic civil litigation on an aggregate basis - chiefly, though not exclusively, by way of class actions. European systems have shown a growing receptiveness for aggregate litigation, but treatments of this development have consisted largely of description. This article offers an analytical framework with which to anticipate the structural dynamics of transnational aggregate litigation in the twenty-first century.

For a quick reference of recent ‘developments in aggragate litigation’ in Europe, see the table from page 19 (20 of 47).

In the second article, in the The Times newspaper, Edwin Coe LLP’s David Greene politely warns ‘Hands off our claimants, please’. ‘Is there a head of steam building up to introduce US-style class action to Britain? Consumers will not be so lucky.’ Greene, partner and head of litigation, discusses among other things the export of cases by way of the US plaintiffs’ bar’s efforts ‘recruiting claimants in the UK’ and the corresponding growth of UK claimants’ participation in US actions. (In WV&Z’s view, ‘participation’ is moving to be and, once appointed, acting as lead plaintiff and not the just filling out and filing of a settlement claim form.) Cited cases include Vivendi, GSK and the English case MAN v Freightliner (opinion). He then goes on to discuss the flipside, the barriers of the development of ‘US-style class actions’ over here - ‘loser pays’, lack of contingency fees and ’simply the state of the law’.

Edwin Coe is the firm that represents 6,000 - the number is growing - private shareholders in the nationalised mortgage lender Norther Rock Plc. (Also see this article.) WV&Z waits with bated breath for that case to commence.

Converium class includes SWX, NYSE

Friday, April 18th, 2008

The post I wrote on 16 January 2007 about Converium Reinsurance Co being partially granted and partially denied its motion to dismiss the class action pending against it following its IPO never did find its way here. It was in the earliest days of WV&Z and on the basis of the case I actually went on a tangent about disclosure and the Transparancy Directive and never did finish the post properly. So, nudged by SLW (this post, with thanks), some of that material, the important stuff on the case itself, does find its way here now in updated form. (I’ll spare you the rest.)

In her December 2006 opinion (via New York Law Journal), SDNY Judge Denise Cote dismissed the claims against former parent Zurich Financial Services and its underwriters UBS AG and Merrill Lynch International and certain claims against Converium Holding AG and three Converium officers, but not all. Even so, back then it was presented as if it was a dismissal (New York Law Journal, AFX News). (Converium was part of Zurich Financial Services before being spun off; it’s now known as SCOR Holding (Switzerland) AG, SWX: CHRN; NYSE: CHR) Far from that being the end, litigation of course continued on the basis of what was left, the Securities Act claims and the remaining Exchange Act claims. (Also see the consolidated amended complaint, September 2005.)

Fast forward a good year and Judge Cote has partially granted and partially denied a motion to certify the class in the action. (SLW has the March 2008 opinion.) She specifically denies ‘to include foreign investors who purchased shares on a foreign exchange’ (WV&Z archives) but includes ‘United States residents who purchased Converium shares on the SWX [and] any person who purchased Converium ADSs on the NYSE’. See the opinion from page 7 for the discussion on subject matter jurisdiction over non-US purchasers on the Swiss exchange in this case.

Notably, the certification denies Co-Lead Plaintiff Avalon Holdings Inc., an institutional investor based in Greece, being a member of the class. In response to SLW’s final observation then, WV&Z points to Avalon as most likely to lead that charge.

What’s more: Also see Prof Samuel P. Baumgartner’s 2007 paper Class Actions and Group Litigation in Switzerland.

PwC’s 2007 Study, with a foreign flavour

Thursday, April 17th, 2008

One of the main themes of PricewaterhouseCooper’s 2007 Securities litigation study is in relation to foreign issues, involving both issuers and purchasers. In her introductory observation (page 1 of 77, all pages ‘of 77′), Grace Lamont, Partner and Leader of the Securities Litigation Practice, states among other things that ‘[w]ith the European Union and individual countries seemingly poised to consider collective litigation alternatives [to US class action litigation], 2008 could prove just as transformative in the foreign markets’.

Skip to the chapter ‘What a difference a year makes’ (p. 56) and the article ‘Global class actions’ (p. 70, contributed by Allen & Overy LLP) for the analysis. (Also see the Gibson Dunn & Crutcher LLP contribution, p. 45)

In short, the number of actions against foreign issuers is well up, to 27 from 14 in 2006. Of the 27, ten are European which is higher than the 2000 - 2006 average of 7. Settlement values too are up. The average settlement amount of the fifteen settlements was US$253.3 million (2006: US$149 million) or US$26.6 million (US$11.7 million) excluding outlier settlements. The Royal Dutch Shell Plc settlement (WV&Z archive) was not taken into account in these figures as that is a European settlement. (For the NAPF paper referred to on p. 66, see this previous post.)

For last year’s study, see this previous post and for more commentary on this year’s, see the D&O Diary and The 10b-5 Daily.

White Paper for collective redress

Monday, April 7th, 2008

The European Commission has presented a White Paper on actions for damages, ’suggesting a new model for achieving compensation for consumers and businesses who are the victims of antitrust violations’. One of the key recommendations is that of collective redress in particular for small value claims.

‘However, safeguards to avoid that such actions would lead to unfounded claims need to be put in place. In the field of antitrust, the Commission therefore recommends allowing only representative actions led, for example, by recognised consumer groups and actions in which victims can choose to participate, as opposed to class actions run by law firms for an unidentified number of claimants.’ (press release, related documents)

The paper follows the Commission’s Green Paper (2005) on the same topic. (press release) See also SJ Berwin LLP’s latest Community Week, today’s The Lawyer for an article by Weil, Gotshal & Manges LLP’s Matthew Shankland and Competition Commissioner Neelie Kroes’ remarks on the White Paper.

order abilify
acai uk
accutane rx
aciphex medication side effects
acomplia dose
actonel on line
remedios caceros actos de amor
aleve dosage
effects of allegra d
ALLI COUPON
altace dosage
bladder infection antibiotics
order aricept
cheap arimidex online
online ashwagandha
astelin medicine
generic for atacand
buy atarax online
order augmentin
avandia pancreatitis
avapro oral
avodart rx
online bactrim
toddler benadryl dose
benicar sexual side effects
Biaxin Dosage
buspar drug test
cardizem and rbbb
buying celebrex
celadrin
cephalexin side effects dogs
cheap cialis no prescription
cipro information
cla no prescription
how quickly does clarinex work
claritin on line
sixth cycle of clomid not working
clonidine autism
colchicine information
side effects of coreg cr
coumadin sheep
Cozaar medication
Side Effects of Creatine
buy crestor
online cymbalta
online cymbalta
depakote drugs
cheap diclofenac no prescription
cheap differin online
diflucan tablet
diovan without prescription
doxycycline withdrawal
cheap effexor no prescription
flagyl canada
FLOMAX NOZZLE
glucophage xr
smoking and hair loss
Good for a Hangover
side effects of hoodia
keppra and migraines
lamictal tablets
lamisil xr
lasix without a prescription
levaquin 250mg
levitra use
lexapro fda
lipitor usa
lisinopril interaction with sweetener
alfred Lewy melatonin jet lag
metformin canada
Methotrexate Drug Side Effects
micardis drugs
online mobic
cheap motrin
msm news
neurontin xr
cost of nexium
nizoral 2%
buy nolvadex
mail order omnicef
paxil interactions
penis extender results
Buy phentermine cheap medication
discount phosphatidylserine
buying plan b
cheap plavix
pravachol drugs
prednisone information
Premarin law suit
prevacid drugs
does prometrium work fast
How Much Does Propecia Cost
side effects of provera
prozac and weight gain
reglan buy
generic reminyl online
rimonabant price
risperdal acne
purchase rogaine
cheapest seroquel
singulair side effects
no rx skelaxin online
Stop Smoking Medications
Need Side Effects of Strattera
cheap stress relief
synthroid mg
treating a boil with tetracycline
topamax no prescription
cheap toprol no prescription
What Is Toradol Used for
Is Tramadol a Narcotic
trazodone withdrawls
tricor abbott labratories
ritalin and trileptal
Tramadol Ultracet
valtrex rx
no rx viagra
no rx voltaren
vytorin news
weight loss xr
wellbutrin xr
Yohimbe Bark Extract Pausinystalia yohimba
Zantac And Gynecomastia
problems with Zetia
zestoretic no prescription
Zithromax Used for Treating
zoloft causes high cholesterol
zovirax suppositories
Zyban lab report
zyprexa 4 years
purchase zyrtec
discount zyvox

Wrapping it up, 7 April 2008

Monday, April 7th, 2008

John M. Gray holds several functions at public services union UNISON and is a pension representative at the Local Government Pension Scheme (LGPS). In addition, he keeps John’s Labour blog, on political and trade union issues. Bearing that in mind, to read his account of a Trades Union Congress seminar on class actions and plaintiffs’ lawyers in the UK see his post Class Action at the TUC.

Also of interest, an article by Barlow Lyde & Gilbert LLP (first published in The Banker) elaborating on the UK claimant situation following the ‘credit crunch’ after a brief comparison with the US.

And one off the shelf is a January article in The Lawyer, on Proskauer Rose LLP’s 2008 Trends and Developments report. (press release) One of the trends in the report is ‘[t]he continued (albeit lamented) “Americanization” of non-US legal systems’ (from page 11). (Subscribe to WV&Z.)

What when where: US Chamber, updated

Wednesday, April 2nd, 2008

Henry M. Paulson Jr., Secretary of the Treasury was a last-minute addition to the roster of speakers last week at the US Chamber’s Capital Markets Competitiveness conference. (See previous post.)

Transcripts of most of the speeches, including Paulson’s, are available from the Chamber’s Center for Capital Markets Competitiveness section. The conference was webcast live and once the archive is ready, it will become available again (here). And finally, another report was launched on the day, with the same title as this year’s conference, namely Strengthening U.S. Capital Markets - A Challenge for All Americans.

BP Plc settles US derivative action

Wednesday, April 2nd, 2008

BP Plc (LSE, NYSE: BP) has settled the derivative litigation pending against it. (3AN-06-11929CI, Unite Here National Retirement Fund et al vs. The Lord John Browne of Madingley et al; See WV&Z’s archive for previous posts). The notice of and terms of the settlement and more documents relating to the action can be found in BP’s Corporate Governance section and Lead Counsel Coughlin Stoia Geller Rudman & Robbins LLP’s settled cases section.

The action has not satisfactorily established that English corporations can be sued derivately in a US Court under the English Companies Act 2006, which allows for derivative claims. Instead, the Court had denied BP’s motion to dismiss on the grounds that Alaska law is applicable and that the case should not be dismissed on the basis of forum non conveniens.

The Court is to hold the settlement fairness hearing on 7 May 2008 at 2pm. The deadline to object to the settlement is 23 April. (Subscribe to WV&Z here.)


  • on viagra
  • prescription for viagra
  • where to buy viagra on line
  • buy propecia online
  • online viagra pharmacy
  • order viagra
  • buy generic viagra
  • tadalafil cialis